Brief: Charmacy Pharmaceutical Posts FY Net Profit Attributable Of RMB44.76 Mln
March 22 (Reuters) - Charmacy Pharmaceutical Co Ltd
2289.HK :
* BOARD RECOMMENDS DISTRIBUTION OF A FINAL DIVIDEND OF
RMB0.20
PER SHARE
* FY OPERATING REVENUE OF GROUP RMB4,095.84 MILLION, UP
11.61%
* FY NET PROFIT ATTRIBUTABLE RMB44.76 MILLION, DOWN 20.72%
* PLANS TO INVEST RMB165 MILLION IN CONSTRUCTION PROJECT TO
BUILD
CHARMACY (GUANGZHOU) PHARMACEUTICAL SORTING & DISTRIBUTION
CENTER
Source text for Eikon: ID:nHKSv9y4K
Further company coverage: 2289.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Charmacy Pharmaceutical Co
See all newsBrief: Charmacy Pharmaceutical Sees Decrease In Net Profit Attributable By 45% For Year
Brief: Charmacy Pharmaceutical Says Yao Chuanglong Ceased To Be Chairman
Brief: Charmacy Pharmaceutical Posts FY Operating Revenue RMB4,175.28 Million
Brief: Charmacy Pharmaceutical Says Controlling Shareholder To Provide Loan Facility
Brief: Charmacy Pharmaceutical Says Applied For Trading Resumption From Feb 17